Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system with a dismal prognosis. Locoregional failure is common despite high doses of radiation therapy, which has prompted great interest in developing novel strategies to radiosensitize these cancers. Our group pre...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Paradkar, Sateja, Herrington, James, Hendricson, Adam, Hewawasam, Piyasena, Plummer, Mark, Hoyer, Denton, Sundaram, Ranjini K., Surovtseva, Yulia V., Bindra, Ranjit S.
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2021
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092340/
https://ncbi.nlm.nih.gov/pubmed/33953843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27933
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items